Amit Sachdev - 17 Feb 2026 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP Chief Patient & Ext Af Off
Signature
/s/ Christiana Stevenson, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
17 Feb 2026
Net transactions value
-$1,035,225
Form type
4
Filing time
19 Feb 2026, 16:24:59 UTC
Previous filing
18 Feb 2026
Next filing
23 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Sachdev Amit EVP Chief Patient & Ext Af Off C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON /s/ Christiana Stevenson, Attorney-in-Fact 19 Feb 2026 0001406338

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Award $0 +5,789 +8.9% $0.000000 71,182 17 Feb 2026 Direct F1
transaction VRTX Common Stock Tax liability $1,035,225 -2,140 -3% $483.75 69,042 17 Feb 2026 Direct
holding VRTX Common Stock 882 17 Feb 2026 401(k)
holding VRTX Common Stock 9,301 17 Feb 2026 Held in Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit award that vests in installments beginning on February 20, 2027.